Back to mobile site

Cyclacel Pharma (CYCC) Misses Q1 EPS by 227c

May 14, 2024 5:00 PM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($2.27).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings